We are live on ! Find out more
GIM

Glenmede Investment Management Portfolio holdings

AUM $20.7B
This Fund
S&P 500
This Quarter Est. Return
+9.24%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$19.8B
AUM Growth
Cap. Flow
+$18.6B
Cap. Flow %
94.03%
Top 10 Hldgs %
24.76%
Holding
1,498
New
1,498
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 23.26%
2 Financials 11.2%
3 Healthcare 8.68%
4 Consumer Discretionary 8.36%
5 Industrials 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLBD icon
1476
Blue Bird Corp
BLBD
$2.1B
$647 ﹤0.01%
+15
New +$571
JBIO
1477
Jade Biosciences
JBIO
$1.42B
$529 ﹤0.01%
+53
New +$1.8K
PNTG icon
1478
Pennant Group
PNTG
$1.33B
$477 ﹤0.01%
+16
New +$439
APLD icon
1479
Applied Digital
APLD
$8.55B
$241 ﹤0.01%
+24
New +$177
ALMS
1480
Alumis Inc
ALMS
$3.23B
$234 ﹤0.01%
+78
New +$368
ARDX icon
1481
Ardelyx
ARDX
$1.02B
$152 ﹤0.01%
+39
New +$161

Similar funds

Glenmede Investment Management's Q2 2025 Portfolio in Review

Q2 2025 is the first quarter with a 13F filing on record for Glenmede Investment Management, which disclosed 1,498 positions worth $19.8B. Its ten largest holdings account for 25% of the portfolio.

Its largest position is Vanguard S&P 500 ETF: 1,621,868 shares worth $921M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, followed by Financials and Healthcare.

  • Glenmede Investment Management's largest Q2 2025 buy was Vanguard S&P 500 ETF: 1,621,868 shares worth $921M.
  • Glenmede Investment Management's ten largest holdings make up 25% of its $19.8B portfolio in Q2 2025.
  • Glenmede Investment Management disclosed 1,498 positions in Q2 2025, its first 13F filing on record.

Based on Glenmede Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.